Jefferies Group LLC Verrica Pharmaceuticals Inc. Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$9.77 - $15.33 $1.09 Million - $1.72 Million
-112,000 Closed
0 $0
Q1 2021

Sep 21, 2023
BUY
$10.51 - $17.46 $1.18 Million - $1.96 Million
112,000 New
112,000 $1.7 Million
Q1 2021

May 14, 2021
BUY
$10.51 - $17.46 $1.18 Million - $1.96 Million
112,000 New
112,000 $1.7 Million

Others Institutions Holding VRCA

# of Institutions
71
Shares Held
17.4M
Call Options Held
6.1K
Put Options Held
6.3K
View Full List

About Verrica Pharmaceuticals Inc.

VRCA Quotes by TradingView
  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email